Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
School of Mechanical Engineering, Purdue University , West Lafayette, Indiana 47907, United States.
ACS Appl Mater Interfaces. 2016 Aug 31;8(34):21848-60. doi: 10.1021/acsami.6b01194. Epub 2016 May 2.
A significant challenge facing tissue engineers is the design and development of complex multitissue systems, including vascularized tissue-tissue interfaces. While conventional in vitro models focus on either vasculogenesis (de novo formation of blood vessels) or angiogenesis (vessels sprouting from existing vessels or endothelial monolayers), successful therapeutic vascularization strategies will likely rely on coordinated integration of both processes. To address this challenge, we developed a novel in vitro multitissue interface model in which human endothelial colony forming cell (ECFC)-encapsulated tissue spheres are embedded within a surrounding tissue microenvironment. This highly reproducible approach exploits biphilic surfaces (nanostructured surfaces with distinct superhydrophobic and hydrophilic regions) to (i) support tissue compartments with user-specified matrix composition and physical properties as well as cell type and density and (ii) introduce boundary conditions that prevent the cell-mediated tissue contraction routinely observed with conventional three-dimensional monodispersion cultures. This multitissue interface model was applied to test the hypothesis that independent control of cell-extracellular matrix (ECM) and cell-cell interactions would affect vascularization within the tissue sphere as well as across the tissue-tissue interface. We found that high-cell-density tissue spheres containing 5 × 10(6) ECFCs/mL exhibit rapid and robust vasculogenesis, forming highly interconnected, stable (as indicated by type IV collagen deposition) vessel networks within only 3 days. Addition of adipose-derived stromal cells (ASCs) in the surrounding tissue further enhanced vasculogenesis within the sphere as well as angiogenic vessel elongation across the tissue-tissue boundary, with both effects being dependent on the ASC density. Overall, results show that the ECFC density and ECFC-ASC crosstalk, in terms of paracrine and mechanophysical signaling, are critical determinants of vascularization within a given tissue compartment and across tissue interfaces. This new in vitro multitissue interface model and the associated mechanistic insights it yields provide guiding principles for the design and optimization of multitissue vascularization strategies for research and clinical applications.
组织工程师面临的一个重大挑战是设计和开发复杂的多组织系统,包括血管化的组织-组织界面。虽然传统的体外模型侧重于血管生成(新血管的形成)或血管生成(从现有血管或内皮单层长出的血管),但成功的治疗性血管化策略可能依赖于这两个过程的协调整合。为了应对这一挑战,我们开发了一种新的体外多组织界面模型,其中将人内皮集落形成细胞(ECFC)包封的组织球嵌入周围的组织微环境中。这种高度可重复的方法利用双亲表面(具有明显的超疏水和亲水区域的纳米结构化表面)来:(i)支持具有用户指定基质组成和物理特性以及细胞类型和密度的组织隔室;(ii)引入边界条件,以防止与常规三维单分散培养中通常观察到的细胞介导的组织收缩。该多组织界面模型用于测试以下假设:细胞-细胞外基质(ECM)和细胞-细胞相互作用的独立控制将影响组织球内以及组织-组织界面处的血管生成。我们发现,含有 5×106/mL ECFC 的高密度组织球迅速且强劲地发生血管生成,仅在 3 天内形成高度相互连接、稳定的(如 IV 型胶原沉积所示)血管网络。在周围组织中添加脂肪来源的基质细胞(ASCs)进一步增强了球内的血管生成以及穿过组织边界的血管生成性血管伸长,这两种作用都依赖于 ASC 的密度。总的来说,结果表明,ECFC 密度和 ECFC-ASC 串扰(涉及旁分泌和力学信号)是决定特定组织隔室和组织界面内血管生成的关键决定因素。这种新的体外多组织界面模型及其产生的机制见解为研究和临床应用的多组织血管化策略的设计和优化提供了指导原则。